AIM: To examine trends in and correlates of liver disease and viral hepatitis in an human immunodeficiency virus (HIV)-infected cohort. METHODS: The multi-site adult/adolescent spectrum of HIV-related diseases (ASD) followed 29 490 HIV-infected individuals receiving medical care in 11 U.S. metropolitan areas for an average of 2.4 years, and a total of 69 487 person-years, between 1998 and 2004. ASD collected data on the presentation, treatment, and outcomes of HIV, including liver disease, hepatitis screening, and hepatitis diagnoses. RESULTS: Incident liver disease, chronic hepatitis B virus (HBV), and hepatitis C virus (HCV) were diagnosed in 0.9, 1.8, and 4.7 per 100 person-years. HBV and HCV screening increased from fewer than 20% to over 60% during this period of observation (P < 0.001). Deaths occurred in 57% of those diagnosed with liver disease relative to 15% overall (P < 0.001). Overall 10% of deaths occurred among individuals with a diagnosis of liver disease. Despite care guidelines promoting screening and vaccination for HBV and screening for HCV, screening and vaccination were not universally conducted or, if conducted, not documented. CONCLUSION: Due to high rates of incident liver disease, viral hepatitis screening, vaccination, and treatment among HIV-infected individuals should be a priority.
AIM: To examine trends in and correlates of liver disease and viral hepatitis in an human immunodeficiency virus (HIV)-infected cohort. METHODS: The multi-site adult/adolescent spectrum of HIV-related diseases (ASD) followed 29 490 HIV-infected individuals receiving medical care in 11 U.S. metropolitan areas for an average of 2.4 years, and a total of 69 487 person-years, between 1998 and 2004. ASD collected data on the presentation, treatment, and outcomes of HIV, including liver disease, hepatitis screening, and hepatitis diagnoses. RESULTS: Incident liver disease, chronic hepatitis B virus (HBV), and hepatitis C virus (HCV) were diagnosed in 0.9, 1.8, and 4.7 per 100 person-years. HBV and HCV screening increased from fewer than 20% to over 60% during this period of observation (P < 0.001). Deaths occurred in 57% of those diagnosed with liver disease relative to 15% overall (P < 0.001). Overall 10% of deaths occurred among individuals with a diagnosis of liver disease. Despite care guidelines promoting screening and vaccination for HBV and screening for HCV, screening and vaccination were not universally conducted or, if conducted, not documented. CONCLUSION: Due to high rates of incident liver disease, viral hepatitis screening, vaccination, and treatment among HIV-infected individuals should be a priority.
Entities:
Keywords:
Hepatitis B; Hepatitis C; Human immunodeficiency virus; Liver disease
Authors: Emma C Thomson; Eleni Nastouli; Janice Main; Peter Karayiannis; Joseph Eliahoo; David Muir; Myra O McClure Journal: AIDS Date: 2009-01-02 Impact factor: 4.177
Authors: Karen A Hennessey; Andrea A Kim; Vivian Griffin; Nicoline T Collins; Cindy M Weinbaum; Keith Sabin Journal: J Urban Health Date: 2008-07-12 Impact factor: 3.671
Authors: Alan R Lifson; Waldo H Belloso; Cate Carey; Richard T Davey; Daniel Duprez; Wafaa M El-Sadr; Jose M Gatell; Daniela C Gey; Jennifer F Hoy; Eric A Krum; Ray Nelson; Daniel E Nixon; Nick Paton; Court Pedersen; George Perez; Richard W Price; Ronald J Prineas; Frank S Rhame; James Sampson; John Worley Journal: HIV Clin Trials Date: 2008 May-Jun
Authors: John D Scott; Anna Wald; Mari Kitahata; Elizabeth Krantz; Linda Drolette; Lawrence Corey; Chia C Wang Journal: AIDS Patient Care STDS Date: 2009-11 Impact factor: 5.078
Authors: Lynne M Mofenson; Michael T Brady; Susie P Danner; Kenneth L Dominguez; Rohan Hazra; Edward Handelsman; Peter Havens; Steve Nesheim; Jennifer S Read; Leslie Serchuck; Russell Van Dyke Journal: MMWR Recomm Rep Date: 2009-09-04
Authors: Philip R Spradling; James T Richardson; Kate Buchacz; Anne C Moorman; Lyn Finelli; Beth P Bell; John T Brooks Journal: J Acquir Immune Defic Syndr Date: 2010-03 Impact factor: 3.731
Authors: James W T Cohen Stuart; Marieke Velema; Rob Schuurman; Charles A B Boucher; Andy I M Hoepelman Journal: J Med Virol Date: 2009-03 Impact factor: 2.327
Authors: Carmen Pittman; Sabrina Plitt; Ted Birse; Karen Doucette; Barbara Romanowski; Rya Cooper; Stan Houston; Stephen Shafran; Ameeta E Singh Journal: Can J Infect Dis Med Microbiol Date: 2014 Impact factor: 2.471
Authors: Robert S Hogg; Oghenowede Eyawo; Alexandra B Collins; Wendy Zhang; Shahab Jabbari; Mark W Hull; Viviane Dias Lima; Tareq Ahmed; Claire E Kendall; Keri N Althoff; Amy C Justice; Rolando Barrios; Jeannie Shoveller; Julio S G Montaner Journal: Lancet HIV Date: 2017-03-03 Impact factor: 12.767